A new experiment heading to the International Space Station will expose tiny, lab-grown models of the human brain to the unusual conditions of space. Scientists hope the results will reveal how brain cells respond to microgravity and help researchers understand the risks astronauts may face during longer missions. The findings could also contribute to research into neurological diseases on Earth.
The human brain is one of the most complicated biological structures ever studied. Yet scientists cannot simply remove living brain tissue from a healthy person, send it into orbit and watch what happens. Instead, they are developing miniature laboratory models made from human cells that reproduce selected features of brain tissue.
Now, NASA is preparing to take this approach further. In an announcement published on October 12, 2026, the agency said a new brain-model investigation would travel to the International Space Station aboard SpaceX’s 35th Commercial Resupply Services mission. The experiment is designed to run for five weeks, comparing tissue models exposed to spaceflight with identical models kept on Earth.
The objective is not to grow a miniature human brain capable of thinking. It is to study what happens at the cellular level when human neural tissue experiences an environment that cannot be fully reproduced in an ordinary laboratory.
That distinction matters. As governments and commercial companies prepare for longer journeys into space, scientists need better ways to understand how the human body responds to prolonged exposure to microgravity and other spaceflight conditions. Tiny brain models could offer a valuable new window into that problem.
What exactly are these tiny human brain models?
The structures at the centre of this research are known as brain organoids or neural organoids. They are three-dimensional clusters of cells grown in a laboratory to reproduce certain characteristics of human brain tissue.
Researchers typically begin with stem cells, which can develop into different specialised cell types under carefully controlled conditions. One important source is induced pluripotent stem cells, or iPSCs. Scientists can create these cells by reprogramming adult cells, such as skin or blood cells, into a stem-cell-like state. With the right chemical signals and culture conditions, these cells can then be guided to develop into neurons and other neural cell types.
The resulting structures are small, but they can display features that flat layers of cells in a conventional laboratory dish cannot easily reproduce. Their three-dimensional organisation allows researchers to investigate aspects of cellular development, communication and responses to disease.
Some organoids are designed to model particular brain regions or neurological conditions rather than the entire brain. For example, researchers can produce neural tissue containing dopaminergic neurons, which are important for movement and are affected in Parkinson’s disease, or cortical-like tissue relevant to other neurological processes.
These are simplified biological models, not complete human brains. They lack many of the structures, connections, blood vessels and sensory inputs that make a functioning human brain possible. They do not reproduce the full complexity of consciousness, memory or human behaviour.
That limitation is also part of their value. By focusing on specific cell types and biological processes, scientists can investigate questions that would be extremely difficult or ethically impossible to study directly in living people.
NASA’s biological and physical sciences research programme includes experiments using human-derived cellular models to investigate how spaceflight affects biological systems. The new brain-model experiment builds on this broader effort to understand how living tissues respond to unusual environments.
Why send brain tissue into space?
The central scientific question is straightforward: what changes when human neural tissue develops or survives in microgravity?
On Earth, gravity influences how fluids move, how cells settle in culture systems and how tissues interact with their surroundings. In orbit, the International Space Station and everything inside it are in continuous free fall around Earth. This produces the condition commonly called microgravity, in which the effects of gravity are greatly reduced relative to everyday experience.
Microgravity does not switch gravity off. Nor does it remove every other influence of spaceflight. Cells aboard the station can still experience radiation, vibration, changes in fluid behaviour and the practical constraints of a spacecraft laboratory. Researchers must account for these factors when interpreting their results.
Nevertheless, the orbital environment offers a distinctive way to investigate biology.
In some laboratory systems, gravity affects how cells aggregate and organise themselves. Microgravity can change those conditions, potentially altering how cells grow, interact and mature. Scientists can compare samples exposed to spaceflight with matched samples maintained on Earth to identify differences associated with the orbital environment.
The five-week brain-model investigation announced by NASA is intended to examine the effects of a short spaceflight at the cellular level. The comparison may help researchers identify biological responses that deserve closer investigation in subsequent experiments.
The work also addresses a practical problem for future human exploration. Astronauts travelling to the Moon, spending extended periods in lunar orbit or eventually journeying to Mars will need protection against the effects of the space environment. Understanding how neural tissue responds is one part of developing that protection.
What scientists hope to discover
1. How microgravity changes brain cells
The first goal is to identify whether neural cells respond differently in space than they do under normal laboratory conditions.
Researchers can examine tissue structure, gene activity and other molecular indicators to determine whether the cells undergo measurable changes. They may investigate processes involved in cellular growth, maturation, stress responses and communication between different types of neural cells.
Genes provide instructions that cells use to make proteins and regulate their activities. When scientists measure changes in gene expression, they can identify biological pathways that appear more or less active under particular conditions.
A difference in gene expression does not automatically mean a cell has been damaged. It may represent an adaptation to a new environment, a temporary stress response or a change in how the cell is developing. Researchers need additional measurements to distinguish between these possibilities.
The most useful outcome may therefore be a clearer picture of which processes change in microgravity, how large those changes are and whether they persist after the tissue returns to Earth.
2. Whether spaceflight alters neural development
A second question concerns the way neurons mature.
Neurons are specialised cells that communicate through electrical signals and chemical messengers. Their development involves changes in their structure, the proteins they produce and the connections they establish with other cells.
A previous experiment provides an important reason to investigate this further.
In a study published in Stem Cells Translational Medicine in 2024, researchers maintained human neural organoids aboard the International Space Station for approximately one month. The models were derived from induced pluripotent stem cells associated with Parkinson’s disease, primary progressive multiple sclerosis and unaffected comparison donors.
The team reported lower expression of genes associated with cell proliferation and higher expression of genes associated with maturation in the space-exposed organoids. The findings suggested that some neural cells might mature more quickly in low Earth orbit, although the researchers emphasised the need for further experiments to understand the underlying mechanisms.
This is a significant lead, but it is not proof that microgravity universally accelerates brain development. The earlier study used specific cell models and experimental conditions, and its results cannot automatically be applied to every kind of neural tissue.
The newer investigation offers an opportunity to expand the evidence. Scientists will want to determine whether changes observed in one set of models can be reproduced, whether they depend on the type of cells involved and how the cells respond to the space environment over time.
3. What the findings could mean for astronaut health
Spaceflight affects the human body in several ways. Astronauts experience changes in fluid distribution, balance, sleep patterns and other physiological processes. The space environment also exposes crews to radiation that is substantially different from the radiation environment on Earth’s surface.
Understanding the nervous system’s response is especially important because astronauts must make complex decisions, coordinate movements and maintain attention during demanding operations.
A five-week organoid experiment cannot directly measure memory, judgement, mood or cognitive performance. Those functions depend on networks spanning many brain regions and interactions with the rest of the body.
However, laboratory models can help researchers investigate cellular mechanisms that may be relevant to neurological health. If an experiment identifies changes in stress-response pathways, neuronal maturation or other processes, scientists can examine whether similar patterns appear in additional models or in physiological measurements collected from astronauts.
Over time, this evidence could help researchers identify potential risks and develop countermeasures worth testing. Those might include changes to mission health monitoring, preventive strategies or treatments that protect particular biological processes.
Such applications remain possibilities rather than established outcomes. The immediate task is to determine what changes actually occur and whether they matter for human health.
4. Could brain organoids help researchers study neurological diseases?
One of the most promising aspects of this research is its potential relevance to conditions that affect millions of people on Earth.
Parkinson’s disease, multiple sclerosis and Alzheimer’s disease differ considerably, but each involves complex biological processes that cannot be fully understood by examining symptoms alone. Scientists need ways to study how cells behave, how they interact and how disease-related changes develop.
Brain organoids provide one possible route.
Researchers can create models from induced pluripotent stem cells derived from people with particular diseases. These models may preserve some donor-specific biological characteristics, allowing scientists to investigate disease-related mechanisms in human cells.
Previous space-based studies have already used this approach. NASA has documented research involving organoids derived from people with Parkinson’s disease and primary progressive multiple sclerosis, including investigations of neuroinflammation and interactions between neural cells and microglia. Microglia are immune-related cells that help maintain the brain’s environment and respond to injury or disease.
Why conduct some of this work in orbit? Because microgravity may alter cellular behaviour in ways that make certain biological processes easier to observe or investigate. It could help researchers identify pathways that are difficult to separate under conventional laboratory conditions.
There is an important caveat: a change that appears in a space-exposed model is not necessarily a feature of the disease itself. Researchers must determine whether the effect comes from microgravity, another aspect of spaceflight, the culture system or an interaction between these factors.
Nor does a promising result mean that a treatment is ready for patients. Findings from organoids need to be tested in additional experimental systems, and potential therapies must undergo appropriate preclinical and clinical evaluation.
Still, these models could help researchers decide which biological mechanisms deserve further attention and which potential drug targets warrant investigation.
5. Can scientists learn to protect the brain before humans travel to Mars?
A journey to Mars would expose astronauts to a much longer and more complex spaceflight environment than a short trip to the International Space Station.
The journey would involve prolonged microgravity, increased exposure to space radiation compared with life on Earth’s surface and limited access to medical facilities. Once astronauts arrive, they would also need to operate in an unfamiliar environment while managing the demands of an extended mission.
Researchers cannot safely recreate every aspect of such a journey in human volunteers. That makes laboratory models particularly useful for investigating some of the underlying biology.
Brain organoids could help researchers identify cellular changes associated with spaceflight and test whether particular interventions alter those responses. Scientists might compare untreated tissue with samples exposed to candidate protective treatments, for example, although any promising result would need further validation.
A key challenge will be separating the effects of microgravity from those of radiation, stress, altered sleep and other factors. Experiments using cells alone cannot reproduce the complete human response, so organoid findings will need to be considered alongside animal studies, astronaut health data and other research.
The long-term objective is not simply to learn whether neural cells change in space. It is to establish which changes matter, whether they can be prevented and how future crews can be protected.
How will scientists study the samples?
The experimental design matters as much as the biological question.
NASA’s October 2026 announcement describes a five-week investigation in which brain tissue models exposed to spaceflight will be compared with identical models kept on Earth. This paired approach gives researchers a reference point for assessing changes associated with the orbital experiment.
Researchers can use several complementary techniques to investigate biological differences.
Gene-expression analysis: Identifies changes in which genes are active and helps reveal affected biological pathways.
Microscopy and tissue analysis: Shows how cells are arranged and whether the structure of the models has changed.
Molecular measurements: Can reveal differences in proteins and other molecules associated with cellular function or stress.
Comparisons with Earth-based controls: Help researchers determine whether observed differences are reproducible and associated with the spaceflight conditions.
The exact conclusions scientists can draw will depend on the measurements collected, the quality of the samples and the experimental controls. A five-week study can provide valuable evidence, but it cannot settle every question about long-duration spaceflight.
Earlier work demonstrates that this type of research is feasible. In the 2024 study, investigators maintained neural organoids in orbit for about 30 days, returned the samples to Earth and analysed them using gene-expression methods and tissue examination.
The next step is to build on such findings with better-controlled experiments and a broader understanding of the mechanisms involved.
What these experiments cannot tell us yet
The phrase “lab-grown human brain” can create a misleading impression. These models are not miniature people, and they are not complete brains inside containers.
Brain organoids reproduce selected features of neural tissue, but they do not replicate the full architecture and functioning of a human brain. Many lack the extensive vascular systems and long-range connections needed to model an intact brain. Their development and cellular composition can also vary between batches.
These limitations affect how researchers interpret the results.
For example, a change in the activity of a gene involved in neuronal maturation does not prove that a human astronaut’s brain will undergo the same change. Similarly, evidence of cellular stress does not automatically demonstrate cognitive impairment or permanent neurological damage.
The experiment also cannot establish that microgravity alone is responsible for every observed difference. Spaceflight involves several environmental factors, and researchers need appropriate controls to distinguish their effects.
The most scientifically valuable reporting will therefore avoid treating preliminary findings as medical breakthroughs. Any claims about treatments for neurological diseases or protection against cognitive decline will require evidence beyond this experiment.
Why the research matters beyond space exploration
There is a broader reason to pay attention to experiments like this one.
Scientists often develop new research methods to solve a problem in one field and later discover applications elsewhere. In this case, the immediate challenge is understanding human health during spaceflight. But the techniques used to grow and analyse human neural tissue could also contribute to research on disease mechanisms and drug development on Earth.
Organoids give researchers access to simplified models of human cells that would otherwise be difficult to study directly. They cannot replace every other research method, but they can provide information that conventional cell cultures or animal models may not capture in the same way.
Space also offers a distinctive environment in which to investigate how cells behave when normal gravitational conditions change. If researchers identify reproducible biological effects, those findings may generate new questions about cellular development, tissue organisation and disease.
The path from an orbital experiment to a useful medical application is long. It involves replication, mechanistic studies, validation and, where a treatment is proposed, rigorous testing for safety and effectiveness.
Even so, the potential scientific value extends beyond the astronauts who may one day travel to Mars.
The next frontier in studying the human brain
The experiment announced by NASA represents another step in a growing effort to understand human biology beyond Earth. Tiny laboratory-grown neural models give scientists a way to investigate cellular responses that cannot be examined directly in astronauts.
The questions are fundamental. Does microgravity alter how neural cells mature? Which biological pathways respond to the space environment? Are those changes temporary, and could any of them affect the health of people travelling on long missions?
The answers will not arrive from a single experiment. Researchers will need to compare results across different cell models, missions and laboratory conditions before drawing firm conclusions.
But the approach offers something valuable: a way to study selected aspects of human neural biology under conditions that are difficult to reproduce on Earth.
As NASA and its partners prepare for more ambitious human exploration, that knowledge could become increasingly important. And if the findings eventually help researchers understand neurological disease more clearly, an experiment designed to protect astronauts may also contribute to medical research much closer to home.
